Global Cancer Diagnostics Partnering Deal Trends, Players, Financials and Forecasts 2010-2015
DUBLIN, July 08, 2015 /PRNewswire/ --
Research and Markets(http://www.researchandmarkets.com/research/jblp9t/global_cancer) has announced the addition of the "Global Cancer Diagnostics Partnering 2010-2015: Deal trends, players, financials and forecasts" report to their offering.
The Global Cancer Diagnostics Partnering 2010-2015 report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an understanding and analysis of how and why companies enter cancer diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
This report provides details of the latest cancer diagnostics agreements announced in the healthcare sectors covering the following diagnostics types:
- Diagnostics
- Companion
- Imaging
- CT
- Endoscope
- Molecular and nuclear
- PET
- SPECT
- MRI
- Ultrasound
- X ray
- Angiography
- Fluoroscopy
- Mammography
- In vitro diagnostics
- Molecular diagnostics
- Prognostics
- Theranostics
Report scope:
Global Cancer Diagnostics Partnering 2010-2015 includes:
- Trends in cancer diagnostics dealmaking in the biopharma industry since 2010
- Analysis of cancer diagnostics deal structure
- Access to headline, upfront, milestone and royalty data
- Access to over 1,000 cancer diagnostics deal records
- The leading cancer diagnostics deals by value since 2010
- Includes companion, imaging, CT, MRI, ultrasound, in vitro, molecular, prognostics and theranostics diagnostics deals and alliances since 2010
In Global Cancer Diagnostics Partnering 2010-2015, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific oncology therapy target
- DIagnostics type
Key Topics Covered:
Executive Summary
Chapter 1 Introduction
Chapter 2 Trends in cancer diagnostics dealmaking
Chapter 3 Average financial deal terms for cancer diagnostics partnering
Chapter 4 Leading cancer diagnostics deals
Chapter 5 Cancer diagnostics dealmaking contracts directory
Chapter 6 Cancer diagnostics dealmaking by specific therapy type
Chapter 7 Cancer diagnostics dealmaking by specific technology type
Chapter 8 Future trends and companies in cancer diagnostics deal making
Chapter 9 Partnering resource center
For more information visit http://www.researchandmarkets.com/research/jblp9t/global_cancer
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article